Medikinet

Methylphenidate Hydrochloride, the active ingredient in Medikinet, is a central nervous system stimulant presented as a tablet for oral use. It treats attention deficit hyperactivity disorder (ADHD) and narcolepsy in children, adolescents and adults.

GNH USA supplies Medikinet as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Medikinet, a central nervous system stimulant, is used in the management of disorders involving attention regulation and wakefulness.

- Attention deficit hyperactivity disorder (ADHD) in children: improves concentration, reduces hyperactivity and impulsivity. - Attention deficit hyperactivity disorder (ADHD) in adults: lessens inattention, improves task completion and reduces impulsive behavior. - Narcolepsy: decreases excessive daytime sleepiness and improves wakefulness.

Common Side Effects: - Insomnia: difficulty falling or staying asleep. - Decreased appetite: reduced hunger leading to weight loss. - Headache: mild to moderate cranial pain. - Nausea: feeling of sickness or urge to vomit. - Stomach pain: abdominal discomfort. - Weight loss: unintended reduction in body weight.

Serious or Rare Side Effects: - Cardiovascular events: chest pain, hypertension, tachycardia. - Psychosis: hallucinations or delusional thinking. - Severe allergic reaction: rash, swelling, difficulty breathing. - Priapism: prolonged, painful erection. - Seizures: convulsive episodes. - Mood swings: severe depression or suicidal thoughts.

Before initiating therapy, clinicians should evaluate relevant health factors and monitor patients regularly. - Cardiovascular assessment: check blood pressure and heart rate prior to treatment. - Growth monitoring: track height and weight in pediatric patients. - Psychiatric history: observe for mood changes or emergence of psychotic symptoms. - Hypersensitivity: avoid in patients with known allergy to methylphenidate. - Store at ambient temperature: keep below 25°C, in the original packaging, and protect from moisture.

Methylphenidate may interact with other medicines, requiring careful review of a patient’s medication list.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Other central nervous system stimulants: increased cardiovascular and CNS stimulation. - Certain antidepressants (e.g., tricyclics): heightened risk of serotonin syndrome.

Moderate Interactions (Monitor Closely):\n- Selective serotonin reuptake inhibitors (SSRIs): possible increase in side‑effect intensity. - Antihypertensive agents: may reduce blood‑pressure‑lowering effect. - Antacids: can alter absorption, requiring timing adjustments.